skip to main content
Language:
Results 1 2 3 4 5 next page
Refined by: language: Russian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase III Study of Gefitinib 250 Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase III Study of Gefitinib 250 Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck
Material Type:
Article 		Add to My Research

Phase III Study of Gefitinib 250 Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1864-1871 [Peer Reviewed Journal]

2009 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2008.17.0530

Full text available

Citations Cited by
2
A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)
A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)
Material Type:
Article 		Add to My Research

A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)

Infekt͡s︡ii͡a︡ i immunitet, 2021-04, Vol.11 (2), p.283-296 [Peer Reviewed Journal]

ISSN: 2220-7619 ;EISSN: 2313-7398 ;DOI: 10.15789/2220-7619-ASB-1699

Full text available

Citations Cited by
3
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013
Material Type:
Article 		Add to My Research

EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013

European urology, 2014-01, Vol.65 (1), p.124 [Peer Reviewed Journal]

Copyright © 2013. Published by Elsevier B.V. ;EISSN: 1873-7560 ;DOI: 10.1016/j.eururo.2013.09.046 ;PMID: 24207135

Digital Resources/Online E-Resources

Citations Cited by
4
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Article 		Add to My Research

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Peer Reviewed Journal]

Elsevier Ltd ;2014 INIST-CNRS ;Copyright Elsevier Limited Mar 9, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61767-X ;PMID: 23312829 ;CODEN: LANCAO

Full text available

Citations Cited by
5
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Material Type:
Article 		Add to My Research

Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2046-2054 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.38.4032 ;PMID: 22547592

Full text available

Citations Cited by
6
The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence
The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence
Material Type:
Article 		Add to My Research

The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence

European urology, 2013-04, Vol.63 (4), p.681 [Peer Reviewed Journal]

Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved. ;EISSN: 1873-7560 ;DOI: 10.1016/j.eururo.2012.11.034 ;PMID: 23219375

Digital Resources/Online E-Resources

Citations Cited by
7
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 4, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)61719-5 ;PMID: 24094768 ;CODEN: LANCAO

Full text available

Citations Cited by
8
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Material Type:
Article 		Add to My Research

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.44.2806 ;PMID: 23816960

Full text available

Citations Cited by
9
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Material Type:
Article 		Add to My Research

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2055-2062 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.39.5848 ;PMID: 22547591

Full text available

Citations Cited by
10
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Material Type:
Article 		Add to My Research

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Journal of clinical oncology, 2012-10, Vol.30 (28), p.3499-3506 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.42.8201 ;PMID: 22949147

Full text available

Citations Cited by
11
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Material Type:
Article 		Add to My Research

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3517-3524 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.48.4410 ;PMID: 23980084

Full text available

Citations Cited by
12
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer
Material Type:
Article 		Add to My Research

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer

European urology, 2014-02, Vol.65 (2), p.467 [Peer Reviewed Journal]

Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved. ;EISSN: 1873-7560 ;DOI: 10.1016/j.eururo.2013.11.002 ;PMID: 24321502

Digital Resources/Online E-Resources

Citations Cited by
13
Soil C and N availability determine the priming effect: microbial N mining and stoichiometric decomposition theories
Soil C and N availability determine the priming effect: microbial N mining and stoichiometric decomposition theories
Material Type:
Article 		Add to My Research

Soil C and N availability determine the priming effect: microbial N mining and stoichiometric decomposition theories

Global change biology, 2014-07, Vol.20 (7), p.2356-2367 [Peer Reviewed Journal]

2013 John Wiley & Sons Ltd ;2015 INIST-CNRS ;2013 John Wiley & Sons Ltd. ;ISSN: 1354-1013 ;EISSN: 1365-2486 ;DOI: 10.1111/gcb.12475 ;PMID: 24273056

Full text available

Citations Cited by
14
NxrB encoding the beta subunit of nitrite oxidoreductase as functional and phylogenetic marker for nitrite‐oxidizing Nitrospira
NxrB encoding the beta subunit of nitrite oxidoreductase as functional and phylogenetic marker for nitrite‐oxidizing Nitrospira
Material Type:
Article 		Add to My Research

NxrB encoding the beta subunit of nitrite oxidoreductase as functional and phylogenetic marker for nitrite‐oxidizing Nitrospira

Environmental microbiology, 2014-10, Vol.16 (10), p.3055-3071 [Peer Reviewed Journal]

2013 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd. ;2015 INIST-CNRS ;ISSN: 1462-2912 ;EISSN: 1462-2920 ;DOI: 10.1111/1462-2920.12300 ;PMID: 24118804

Full text available

Citations Cited by
15
Energy homeostasis as an integrative tool for assessing limits of environmental stress tolerance in aquatic invertebrates
Energy homeostasis as an integrative tool for assessing limits of environmental stress tolerance in aquatic invertebrates
Material Type:
Article 		Add to My Research

Energy homeostasis as an integrative tool for assessing limits of environmental stress tolerance in aquatic invertebrates

Marine environmental research, 2012-08, Vol.79, p.1 [Peer Reviewed Journal]

Copyright © 2012 Elsevier Ltd. All rights reserved. ;EISSN: 1879-0291 ;DOI: 10.1016/j.marenvres.2012.04.003 ;PMID: 22622075

Digital Resources/Online E-Resources

Citations Cited by
16
Tricalcium phosphate is inappropriate as a universal selection factor for isolating and testing phosphate-solubilizing bacteria that enhance plant growth: a proposal for an alternative procedure
Tricalcium phosphate is inappropriate as a universal selection factor for isolating and testing phosphate-solubilizing bacteria that enhance plant growth: a proposal for an alternative procedure
Material Type:
Article 		Add to My Research

Tricalcium phosphate is inappropriate as a universal selection factor for isolating and testing phosphate-solubilizing bacteria that enhance plant growth: a proposal for an alternative procedure

Biology and fertility of soils, 2013-05, Vol.49 (4), p.465-479 [Peer Reviewed Journal]

Springer-Verlag 2012 ;2014 INIST-CNRS ;Springer-Verlag Berlin Heidelberg 2013 ;ISSN: 0178-2762 ;EISSN: 1432-0789 ;DOI: 10.1007/s00374-012-0737-7 ;CODEN: BFSOEE

Full text available

Citations Cited by
17
Activity of the T- and B-system of the cell immunity of animals under conditions of oxidation stress and effects of the liposomal drug
Activity of the T- and B-system of the cell immunity of animals under conditions of oxidation stress and effects of the liposomal drug
Material Type:
Article 		Add to My Research

Activity of the T- and B-system of the cell immunity of animals under conditions of oxidation stress and effects of the liposomal drug

Ukrainian journal of ecology, 2017-12, Vol.7 (4), p.536-541 [Peer Reviewed Journal]

ISSN: 2520-2138 ;EISSN: 2520-2138 ;DOI: 10.15421/2017_157

Full text available

Citations Cited by
18
How much land-based greenhouse gas mitigation can be achieved without compromising food security and environmental goals?
How much land-based greenhouse gas mitigation can be achieved without compromising food security and environmental goals?
Material Type:
Article 		Add to My Research

How much land-based greenhouse gas mitigation can be achieved without compromising food security and environmental goals?

Global change biology, 2013-08, Vol.19 (8), p.2285-2302 [Peer Reviewed Journal]

2013 John Wiley & Sons Ltd ;2014 INIST-CNRS ;2013 John Wiley & Sons Ltd. ;ISSN: 1354-1013 ;ISSN: 1365-2486 ;EISSN: 1365-2486 ;DOI: 10.1111/gcb.12160 ;PMID: 23505220

Full text available

Citations Cited by
19
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients
Material Type:
Article 		Add to My Research

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients

Annals of oncology, 2011-03, Vol.22 (3), p.595-602 [Peer Reviewed Journal]

2010 European Society for Medical Oncology ;2015 INIST-CNRS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdq430

Full text available

Citations Cited by
20
Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)
Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)
Material Type:
Article 		Add to My Research

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)

Journal of clinical oncology, 2013-08, Vol.31 (24), p.3004-3011 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;ISSN: 1527-7755 ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.42.3749 ;PMID: 23835708

Full text available

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Refine My Results

New Records 

  1. New From Last Month  (16)
  2. New From Last 3 Month  (78)
  3. More options open sub menu

Resource Type 

  1. Articles  (40,957)
  2. Conference Proceedings  (12)
  3. Books  (1)
  4. More options open sub menu

Language 

  1. English  (19,529)
  2. Japanese  (906)
  3. Ukrainian  (374)
  4. German  (177)
  5. French  (171)
  6. Serbian  (117)
  7. Lingala  (16)
  8. Spanish  (12)
  9. Ganda  (5)
  10. Arabic  (4)
  11. Polish  (4)
  12. Italian  (2)
  13. Bulgarian  (2)
  14. Armenian  (1)
  15. Czech  (1)
  16. Norwegian  (1)
  17. Dutch  (1)
  18. Finnish  (1)
  19. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait